Related references
Note: Only part of the references are listed.The Cytoprotective Effects of Dantrolene: A Ryanodine Receptor Antagonist
Saadet Inan et al.
ANESTHESIA AND ANALGESIA (2010)
Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine Receptor
Hitoshi Uchinoumi et al.
CIRCULATION RESEARCH (2010)
Mapping the Ryanodine Receptor FK506-binding Protein Subunit Using Fluorescence Resonance Energy Transfer
Razvan L. Cornea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor
Zheng Liu et al.
JOURNAL OF CELL SCIENCE (2010)
The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule
Ching-Chieh Tung et al.
NATURE (2010)
Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Markedly Improves the Function of Failing Cardiomyocytes by Stabilizing Interdomain Interactions Within the Ryanodine Receptor
Shigeki Kobayashi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Localization of PKA phosphorylation site, Ser2030, in the three-dimensional structure of cardiac ryanodine receptor
Peter P. Jones et al.
BIOCHEMICAL JOURNAL (2008)
Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene
Gennady Cherednichenko et al.
MOLECULAR PHARMACOLOGY (2008)
Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor
Xing Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Localization of an NH2-terminal disease-causing mutation hot spot to the clamp region in the three-dimensional structure of the cardiac ryanodine receptor
Ruiwu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Malignant hyperthermia
Henry Rosenberg et al.
ORPHANET JOURNAL OF RARE DISEASES (2007)
Ryanodine receptors and ventricular arrhythmias: Emerging trends in mutations, mechanisms and therapies
Christopher H. George et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor
Xiaoli Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mutations in RYR1 in malignant hyperthermia and central core disease
Rachel Robinson et al.
HUMAN MUTATION (2006)
Structural characterization of the RyR1-FKBP12 interaction
M Samsó et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Three-dimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor
MR Sharma et al.
BIOPHYSICAL JOURNAL (2006)
Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death
DW Jiang et al.
CIRCULATION RESEARCH (2005)
Localization of a disease-associated mutation site in the three-dimensional structure of the cardiac muscle ryanodine receptor
Z Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels
SG Priori et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Probing a putative dantrolene-binding site on the cardiac ryanodine receptor
K Paul-Pletzer et al.
BIOCHEMICAL JOURNAL (2005)
Dantrolene stabilizes domain interactions within the ryanodine receptor
S Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Location of divergent region 2 on the three-dimensional structure of cardiac muscle ryanodine receptor/calcium release channel
Z Liu et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Dantrolene - A review of its pharmacology, therapeutic use and new developments
T Krause et al.
ANAESTHESIA (2004)
The predicted TM10 transmembrane sequence of the cardiac Ca2+ release channel (ryanodine receptor) is crucial for channel activation and gating
RW Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mapping sites of potential proximity between the dihydropyridine receptor and RyR1 in muscle using a cyan fluorescent protein-yellow fluorescent protein tandem as a fluorescence resonance energy transfer probe
S Papadopoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Three-dimensional localization of divergent region 3 of the ryanodine receptor to the clamp-shaped structures adjacent to the FKBP binding sites
J Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor)
H Masumiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Three-dimensional reconstruction of the recombinant type 2 ryanodine receptor and localization of its divergent region 1
Z Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ryanodine receptor calcium release channels
M Fill et al.
PHYSIOLOGICAL REVIEWS (2002)
Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor
K Paul-Pletzer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Molecular basis of Ca2+ activation of the mouse cardiac Ca2+ release channel (ryanodine receptor)
P Li et al.
JOURNAL OF GENERAL PHYSIOLOGY (2001)
The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling
K Paul-Pletzer et al.
BIOCHEMISTRY (2001)
Amino acid residues 4425-4621 localized on the three-dimensional structure of the skeletal muscle ryanodine receptor
BL Benacquista et al.
BIOPHYSICAL JOURNAL (2000)
Ca2+ signalling and muscle disease
DH MacLennan
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
